<DOC>
	<DOCNO>NCT02022774</DOCNO>
	<brief_summary>The purpose study evaluate effect fimasartan arterial stiffness patient hypertension</brief_summary>
	<brief_title>Efficacy fimaSartan arTerIal stiFFness iN patiEntS With HypertenSion</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Subjects agree participate study give write informed consent Subjects whose sit diastolic blood pressure measure placebo visit baseline 90 mmHg and/or systolic blood pressure 140 mmHg Subjects naive antihypertensive treatment Subjects consider understand study , cooperative , able followedup end study Subjects hypersensitive angiotensin type 1receptor blocker Subjects secondary hypertension Subjects severe hypertension ( systolic blood pressure &gt; = 180 mmHg OR diastolic blood pressure &gt; = 110 ) Severe cardiac disease ( heart failure , ischemic heart disease , peripheral vascular disease , moderate valvular disease , arrhythmia require treatment , cardiomyopathy , etc . ) Subjects chronic obstructive pulmonary disease history Clinically significant renal dysfunction ( Creatinine 2.0 mg/dL ) liver dysfunction ( ALT , AST &gt; 2x UNL ) Subjects life expectancy le 2 year due noncardiac disease Subjects history evidence abuse drug alcohol within 2 year Severe insulindependent diabetes mellitus intractable diabetic patient ( dose/regimen change oral hypoglycemic agent , insulin use ) Severe cerebrovascular disease ( cerebral infarction , cerebral hemorrhage , within 6 month ) Wasting disease , autoimmune disease ( rheumatoid arthritis , systemic lupus anticoagulant , etc . ) , history connective tissue disease ongoing disease . Women pregnancy breast feed Women plan pregnant without admit contraception despite probability pregnancy ( Women underwent sterilization operation exclude . Fertile woman without surgery undergo pregnancy test participate negative result . Intermittent abstinence like basic body temperature method , natural period method consider admitted contraception hormonal contraception allowed. ) . Subjects participate clinical trial investigate agent take clinical trial medication within 4 week screen visit . Subjects judge inappropriate investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>